Literature DB >> 31915977

The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.

Inhwa Lee1, Hyeung Kyoo Kim1, Euy Young Soh1, Jeonghun Lee2.   

Abstract

BACKGROUND: Whether chronic lymphocytic thyroiditis (CLT) influences the risk of development and the progression of papillary thyroid cancer (PTC) remains uncertain. We investigated the effects of CLT on the clinicopathologic features and prognosis of PTC.
METHODS: Two thousand nine hundred twenty-eight consecutive patients with PTC treated between 2009 and 2017 were divided into two groups: one with chronic lymphocytic thyroiditis and one without; 1174 (40%) of the patients had coincident CLT.
RESULTS: In univariate analysis, CLT correlated positively with small tumor size, frequent extrathyroidal extension, multifocal diseases, and p53 but negatively with central lymph node (LN) metastasis and BRAF mutation. In multivariate analysis, CLT was associated with extrathyroidal extension and multifocal disease; however, it was not a prognostic factor for recurrence even though it was associated with two aggressive factors. Compared with patients with PTC alone, there were more retrieved central LNs in the PTC + CLT group, and these patients also underwent more invasive diagnostic tests such as fine needle aspiration cytology and frozen biopsy of LN.
CONCLUSIONS: The CLT patients with PTC had better behavior features and prognoses than did those with PTC alone despite frequent multifocality and extrathyroidal extension. However, precaution may be necessary to avoid performing invasive diagnostic procedures for lateral LN metastasis and to manage the patients appropriately.

Entities:  

Mesh:

Year:  2020        PMID: 31915977     DOI: 10.1007/s00268-019-05337-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  33 in total

1.  The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.

Authors:  Marina Muzza; Debora Degl'Innocenti; Carla Colombo; Michela Perrino; Elena Ravasi; Stefania Rossi; Valentina Cirello; Paolo Beck-Peccoz; Maria Grazia Borrello; Laura Fugazzola
Journal:  Clin Endocrinol (Oxf)       Date:  2010-05       Impact factor: 3.478

2.  Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis.

Authors:  F Consorti; M Loponte; F Milazzo; L Potasso; A Antonaci
Journal:  Eur Surg Res       Date:  2010-11-05       Impact factor: 1.745

3.  The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.

Authors:  Saki Tomari; Mikio Watanabe; Naoya Inoue; Tomoyo Mizuma; Chika Yamanaka; Yoh Hidaka; Yoshinori Iwatani
Journal:  Endocr J       Date:  2017-08-25       Impact factor: 2.349

4.  The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.

Authors:  Yeo-Hoon Yoon; Hak Joon Kim; Jin Woo Lee; Jin Man Kim; Bon Seok Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-06       Impact factor: 2.503

5.  The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.

Authors:  M P Vanderpump; W M Tunbridge; J M French; D Appleton; D Bates; F Clark; J Grimley Evans; D M Hasan; H Rodgers; F Tunbridge
Journal:  Clin Endocrinol (Oxf)       Date:  1995-07       Impact factor: 3.478

Review 6.  My approach to oncocytic tumours of the thyroid.

Authors:  S L Asa
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

7.  Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.

Authors:  Suk Kyeong Kim; Kee-Ho Song; So Duk Lim; Young Chang Lim; Young Bum Yoo; Ji Soo Kim; Tae Sook Hwang
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

8.  Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods.

Authors:  Renato Tozzoli; Nicola Bizzaro; Elio Tonutti; Marco Pradella; Fabio Manoni; Danilo Vilalta; Danila Bassetti; Anna Piazza; Paolo Rizzotti
Journal:  Clin Chem Lab Med       Date:  2002-06       Impact factor: 3.694

Review 9.  Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?

Authors:  Margret Ehlers; Matthias Schott
Journal:  Trends Endocrinol Metab       Date:  2014-10-09       Impact factor: 12.015

10.  Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis.

Authors:  C Giordano; G Stassi; R De Maria; M Todaro; P Richiusa; G Papoff; G Ruberti; M Bagnasco; R Testi; A Galluzzo
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

View more
  15 in total

1.  Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.

Authors:  Xiao-Xiong Gan; Ya-Yi Li; Si-Jin Li; Shi-Sen Mo; Jian-Hua Feng; Fei Shen; Wen-Song Cai; Ye-Qian Lai; Bo Xu
Journal:  Front Oncol       Date:  2021-08-04       Impact factor: 6.244

2.  A Proposed Heterogeneous Ensemble Algorithm Model for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer.

Authors:  Wenfei Liu; Shoufei Wang; Xiaotian Xia; Minggao Guo
Journal:  Int J Gen Med       Date:  2022-05-06

3.  Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.

Authors:  Qizhi Tang; Weiyu Pan; Liangyue Peng
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

4.  Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.

Authors:  Lirong Wang; Jiawen Chen; Xin Yuan; Juan Wang; Lei Sun; Jue Jiang; Lin Zhang; Min Liu; Qi Zhou
Journal:  BMC Endocr Disord       Date:  2022-01-05       Impact factor: 2.763

5.  Multi-gene assay and clinical characteristics research in papillary thyroid carcinoma.

Authors:  Chang Deng; Shan Li; Zhixin Yang; Yi Dou; Daixing Hu; Jiang Zhu; Denghui Wang; Xinliang Su
Journal:  Gland Surg       Date:  2021-01

6.  Influence Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: Hashimoto's Thyroiditis Has a Weak Effect on Central or Lateral Lymph Node Metastasis.

Authors:  Liguang Zhou; Gang Chen; Lei Sheng; Nan Liu; Bin Zhang; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2021-05-14       Impact factor: 3.989

7.  Incidence of thyroid carcinomas in an extended retrospective study of 526 autopsies.

Authors:  Iuliana Sobaru Mohorea; Bogdan Socea; Dragoş Şerban; Zenaida Ceausu; Adrian Tulin; Violeta Melinte; Mihai Ceausu
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

Review 8.  Papillary Thyroid Cancer Prognosis: An Evolving Field.

Authors:  Salvatore Ulisse; Enke Baldini; Augusto Lauro; Daniele Pironi; Domenico Tripodi; Eleonora Lori; Iulia Catalina Ferent; Maria Ida Amabile; Antonio Catania; Filippo Maria Di Matteo; Flavio Forte; Alberto Santoro; Piergaspare Palumbo; Vito D'Andrea; Salvatore Sorrenti
Journal:  Cancers (Basel)       Date:  2021-11-07       Impact factor: 6.639

9.  Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma.

Authors:  Jiangyue Xu; Ke Ding; Lan Mu; Jiangsheng Huang; Fei Ye; Yu Peng; Can Guo; Chutong Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

10.  Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.

Authors:  Siyuan Xu; Hui Huang; Jiaxin Qian; Yang Liu; Ying Huang; Xiaolei Wang; Shaoyan Liu; Zhengang Xu; Jie Liu
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.